Institutional members access full text with Ovid®

Share this article on:

Application of Adipose-Derived Stem Cells on Scleral Contact Lens Carrier in an Animal Model of Severe Acute Alkaline Burn

Espandar, Ladan M.D., M.S.; Caldwell, Delmar M.D.; Watson, Richard M.D.; Blanco-Mezquita, Tomas M.Sc.; Zhang, Shijia M.D., Ph.D.; Bunnell, Bruce Ph.D.

Eye & Contact Lens: Science & Clinical Practice: July 2014 - Volume 40 - Issue 4 - p 243–247
doi: 10.1097/ICL.0000000000000045
Article

Purpose: To evaluate the therapeutic effect of human adipose-derived stem cells (hASCs) overlaid on a scleral contact lens (SCL) carrier in a rabbit model of ocular alkaline burn.

Materials and Methods: After inducing alkaline burn in 11 New Zealand white rabbits, hASCs cultured on SCLs were placed on the right eye of 5 rabbits, SCLs without cells were used in 5, and no treatment was applied in 1 eye. Each eye was examined and photographed for corneal vascularization, opacities, and epithelial defect in week 1, 2, and 4 after surgery. After 1 month, rabbits were killed and the corneas were removed and cut in half for electron and light microscopy examination.

Results: Human adipose-derived stem cells were attached to SCL surface and confluent easily. Human adipose-derived stem cells on SCL eyes showed smaller epithelial defect, less corneal opacity, corneal neovascularization relative to SCL eyes. Both groups showed no symblepharon. However, the cornea in the untreated eye was melted in 2 weeks and developed severe symblepharon.

Conclusion: Human adipose-derived stem cells on SCL can reduce inflammation and corneal haziness in severe ocular alkaline burn injury in rabbits.

Department of Ophthalmology (L.E.), Duke University Eye Center, Durham, NC; Department of Ophthalmology (D.C., R.W.), School of Medicine, Tulane University, New Orleans, LA; Instituto Oftalmobiologia Aplicada (T.B-M.), University of Valladolid, Valladolid, Spain; Center for Stem Cell Research and Regenerative Medicine (S.Z., B.B.), New Orleans, LA; Department of Pharmacology (S.Z., B.B.), School of Medicine, Tulane University, New Orleans, LA; and Division of Regenerative Medicine (B.B.), Tulane National Primate Research Center, Covington, LA.

Address correspondence to Ladan Espandar, M.D., M.S., Duke University Eye Center, 2351 Erwin Road, DUMC 3802, Durham, NC 27710; e-mail: ladan.espandar@duke.edu

Supported by Department of Ophthalmology Research Fund and in part by CTRECP grant from Tulane University.

The authors have no other funding or conflicts of interest to disclose.

Accepted April 25, 2014

© 2014 Contact Lens Association of Ophthalmologists, Inc.